IRVINE, Calif. and SANTA ROSA, Calif., Nov. 18, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX) and TriVascular Technologies, Inc. (Nasdaq:TRIV) today announced that the U.S. Federal Trade...
SANTA ROSA, Calif., Nov. 9, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation® Abdominal Stent Graft platform, today reported financial...
Improved Patient Outcomes and Compelling Economic Data with the Ovation® Platform and a Fast-Track EndoVascular Aortic Repair (EVAR) Protocol SANTA ROSA, Calif., Nov. 3, 2015 (GLOBE...
Compelling Evidence that the Ovation® System Expands and Improves Endovascular Aortic Repair to More Patients SANTA ROSA, Calif., Nov. 3, 2015 (GLOBE NEWSWIRE) -- TriVascular...
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of TriVascular Technologies, Inc. (NASDAQ:TRIV) (“TriVascular” or “the Company”) in...
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of TriVascular Technologies, Inc. -TRIV PR Newswire BALA CYNWYD, Pa., Oct. 30, 2015 BALA CYNWYD, Pa...
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased TriVascular Technologies, Inc. (NASDAQ: TRIV) stock prior to October 26...
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...
Lifshitz & Miller Law Firm Announces Investigation of Media General, Inc., Piedmont Natural Gas Co., Rite Aid Corporation, Security California Bancorp, Southcoast Financial Corp., The Pep...
Rosen Law Firm, a global investor rights law firm, announces that it is investigating the Board of Directors of TriVascular Technologies, Inc. (NASDAQ:TRIV) for possible breaches of...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約